THIS IS ME. THIS IS MY PROBLEM. I NEED HELP.

Mr. Liver — Pixar-style character lifting weights

Patient

M, 37 YRS

Biometrics

87 KG / 188 CM

My Objective

Seeking peer review from doctors, researchers, or fellow patients to decode anomalous endocrine suppression mediated by chronic HBV inflammation.

My Story / Clinical History

I am 37 years old, and for over a decade, my blood results have indicated something I couldn't name for a long time. ALT — a liver enzyme — has been continuously elevated since 2016, fluctuating between 50 and 75 U/L, even though I have never consumed alcohol and have led an active lifestyle.

In late 2024, I finally discovered the root cause: I am HBsAg-positive. I have chronic Hepatitis B; after an early rise in viral load (768 → 3052 → 4610 IU/mL), the latest PCR now shows <10 IU/mL (detected below assay linear range) after antiviral treatment.

Simultaneously, I uncovered a second issue: my SHBG — a liver-produced protein that binds testosterone — is nearly twice the upper limit and keeps breaking records. The latest result is 97.6 nmol/L (normal < 54).

The outcome is paradoxical: my Total Testosterone is 860 ng/dL (high), but my Free Testosterone — the portion that actually operates within the cells — is at the absolute lower limit, and my FAI (Free Androgen Index) is only 30.55% instead of the required > 35%.

"In other words, my liver produces so much SHBG that it literally binds my own hormone before it can reach my muscles and tissues."

Coupled with this are accompanying markers of chronic inflammation: monocytosis above normal since 2015 (11 years), rising D-dimer, and a slowly climbing AFP — markers I track with growing concern.

Treatment initiated: On March 25, 2026, I started antiviral therapy — Entecavir 0.5 mg daily. This is the beginning of my active fight against the virus. The expectation is HBV-DNA suppression, which may — over time — reduce hepatic inflammation and bring SHBG levels closer to normal.

My Plea

I am looking for doctors, researchers, or patients who have encountered a similar pattern — HBV + Extremely High SHBG + Functional Androgen Deficiency — because this combination is rarely analyzed together, yet its impact on daily functioning is profoundly real.

My Working Thesis

Chronic HBV replication → Hepatic Inflammation → Massive SHBG Upregulation → Functional Androgen Deficiency & Systemic Exhaustion.

⚕ ACTIVE TREATMENT

Entecavir 0.5 mg/day

Since Mar 25, 2026

⚕ SUPPLEMENTATIONS (per day)

  • Witamina D 4000 IU
  • CoQ10 Ubiquinol 3x 100mg
  • Omega 3 1000mg
  • Magnez 300mg

My Vital Biomarkers / JUN '26

Entecavir Therapy Day: —

HBV-DNA PATHOGEN (2026-06-25)
<10 IU/mL
STRONG SUPPRESSION*
SHBG BINDING PROTEIN (2026-03-24)
97.6 nmol/L
PATHOLOGICAL MAX
FREE ANDROGEN INDEX (2026-03-24)
30.5%
SEVERE SUPPRESSION

My Data Timeline

Viral Load vs. Liver Enzymes

ALT has improved from 60 (Mar) to 49 (May) to 42 (Jun), while HBV-DNA dropped from 4610 to <10 IU/mL (below assay linear range). Entecavir 0.5 mg treatment started on March 25, 2026 — marked on the timeline.

The SHBG Sinkhole

Despite robust Total Testosterone production, the aggressive surge in SHBG binds and neutralizes my bioavailable hormones.

Insulin Sensitivity Tracker

HOMA-IR spikes indicating periodic insulin resistance have been largely mitigated via strict lifestyle interventions, proving my primary issue is hepatic, not metabolic.

Chronic Inflammation Markers

Monocytosis above 9% persists for 11 years and rose again in June (14.7%). Platelets improved from 447 (Mar) to 367 (Jun), while CRP remains last measured in March at 0.75 mg/L.

See full chart on WebSite

My Data Matrix (Mixed Data)

Biomarker ~2019 2022/23 2024 Nov '25 Jan '26 Mar '26 Jun '26* Vector
HBV-DNA (IU/mL) 768 3052 4610 <10 Suppressed
ALT (U/L) 53 47 75 50 53 60 42 Improving
Monocytes (%) 13.5 12.7 14.5 13.7 13.9 14.7 Chronic (11Y)
Total Testosterone (ng/dL) 1054 1033 872 1030 701 860 no data Last: Mar '26
Free Testosterone (pg/mL) 27.7 18.9 19.0 no data Last: Mar '26
SHBG (nmol/L) 78.1 87.7 74.0 80.3 97.6 no data Last: Mar '26
FAI (%) 37.2 34.5 48.3 30.3 30.6 no data Last: Mar '26
LH (mIU/mL) 5.71 8.36 7.14 3.99 no data Last: Mar '26
D-dimer (µg/mL) 0.10 0.19 0.19 0.19 0.44 no data Last: Mar '26
AFP (ng/mL) 2.24 2.27 no data Last: Mar '26
TSAT (%) 53.1 58.6 no data Last: Mar '26

Establish Comms

If you are a medical professional, researcher, or a patient holding corroborating data regarding severe SHBG up-regulation mediated by chronic HBV inflammation—please initiate contact. I need your help.

or email me directly →

Email copied to clipboard